The Biden administration awarded the OnPoint drug-injecting program in New York a $2million annual grant – terminated under President Donald Trump, Art Kleinschmidt of SAMHSA revealed in the New York Post. OnPoint, he said, was “a misguided harm reduction program incompatible with federal law and applicable Executive Orders”.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
